antop schreef op 3 december 2025 20:58:
Advancing rare disease care doesn’t end when the congress does.
#ACAAI2025 reinforced the importance of collaboration in advancing allergy and immunology research. The volume of patient-focused research presented signals ongoing progress toward more patient-driven, evidence-based care in allergy and immunology.
Thank you American College of Allergy, Asthma and Immunology (ACAAI) for creating space for these critical conversations — and to everyone who joined us in Orlando to share insights and ideas.
We left inspired and committed to continuing the dialogue that drives meaningful innovation and progress for underserved rare disease communities.
Together, we’re improving access and outcomes. Let’s keep the momentum going! ??